Statera Biopharma, Inc. (STAB)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.19 Million | -5.08 Million | -240.37 Thousand | -4.61 Million | -6.61 Million | -5.03 Million |
| Net Income | -101.87 Million | -12.09 Million | -3.22 Million | -3.7 Million | -9.84 Million | -2.59 Million |
| Depreciation & Amortization | 255.57 Thousand | 1037.00 | 13.78 Thousand | 18.17 Thousand | 21.08 Thousand | 63.45 Thousand |
| Deferred income taxes | 67.6 Million | -13.5 Thousand | - | - | - | -424.76 Thousand |
| Stock-based compensation | 6.05 Million | 2.69 Million | - | - | - | 13.62 Thousand |
| Change in working capital | 1.06 Million | -51.04 Thousand | 1.1 Million | 105.49 Thousand | -340.34 Thousand | 424.76 Thousand |
| Other non-cash items | -1.3 Million | 7.06 Million | 1.86 Million | -1.02 Million | 3.55 Million | -2.52 Million |
| Investing Cash Flow | 13.46 Million | -9637.00 | 156.78 Thousand | 3.96 Million | 3.88 Million | 5.67 Million |
| Investments in PPE | -182.97 Thousand | -9637.00 | - | - | - | - |
| Acquisitions | 13.64 Million | - | - | - | - | - |
| Investment purchases | - | -679.17 Thousand | -1.24 Million | -7.73 Million | -8.63 Million | -17.22 Million |
| Sales/Maturities of investments | - | 734.61 Thousand | 1.35 Million | 11.69 Million | 12.51 Million | 22.71 Million |
| Other Investing Activities | 13.64 Million | -55.44 Thousand | 48.65 Thousand | 8268.00 | 4552.00 | 186.09 Thousand |
| Financing Cash Flow | 20.98 Million | 5.68 Million | 231 Thousand | 55.21 Thousand | - | 539.99 Thousand |
| Debt repayment | -897.73 Thousand | - | -231 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.34 Million | 2.78 Million | - | - | - | 539.99 Thousand |
| Other Financing Activities | 14.54 Million | 2.9 Million | - | 55.21 Thousand | - | - |
| Accounts receivables | -352.09 Thousand | 380.14 Thousand | -68.47 Thousand | 431.32 Thousand | -201.76 Thousand | 300.76 Thousand |
| Accounts payables | 1 Million | -225.17 Thousand | 196.52 Thousand | -325.83 Thousand | -138.57 Thousand | 124 Thousand |
| Inventory | -1 Million | - | - | - | - | - |
| Other working capital | 1.41 Million | -206.01 Thousand | 980.8 Thousand | -105.49 Thousand | 340.34 Thousand | -424.76 Thousand |
| Cash at beginning of period | 593.86 Thousand | 1650.00 | 11.02 Thousand | 4.23 Million | 6.9 Million | 5.91 Million |
| Cash at end of period | 6.84 Million | 593.86 Thousand | 1650.00 | 3.61 Million | 4.23 Million | 6.9 Million |
| Capital Expenditure | -182.97 Thousand | -9637.00 | - | - | - | - |
| Effect of forex changes on cash | -6651.00 | -27.8 Thousand | 15.49 Thousand | -21.74 Thousand | 52.3 Thousand | -189.98 Thousand |
| Net cash flow / Change in cash | 6.25 Million | 592.21 Thousand | -9370.00 | -613.31 Thousand | -2.67 Million | 983.39 Thousand |
| Free Cash Flow | -28.37 Million | -5.09 Million | -240.37 Thousand | -4.61 Million | -6.61 Million | -5.03 Million |
| Breakdown | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 FY | 2021 Q4 | 2021 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.35 Million | -3.49 Million | -7.75 Million | -101.87 Million | -77.25 Million | -12.73 Million |
| Depreciation & Amortization | 191.75 Thousand | 131.08 Thousand | 120.23 Thousand | 255.57 Thousand | 113.24 Thousand | 139.54 Thousand |
| Deferred income taxes | - | - | - | 67.6 Million | 67.6 Million | - |
| Stock-based compensation | -287.63 Thousand | -1.06 Million | 452.53 Thousand | 6.05 Million | 1.1 Million | 1.17 Million |
| Change in working capital | 3 Million | 3.9 Million | 3.42 Million | 1.06 Million | 2.96 Million | -3.85 Million |
| Other non-cash items | -357.19 Thousand | 354.83 Thousand | 1099.00 | -1.3 Million | -2.65 Million | 820.32 Thousand |
| Investing Cash Flow | - | - | -6454.00 | 13.46 Million | -96.91 Thousand | 13.04 Million |
| Investments in PPE | - | - | -6454.00 | -182.97 Thousand | -96.91 Thousand | -63.26 Thousand |
| Acquisitions | - | - | - | 13.64 Million | 1.00 | 529.5 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 13.64 Million | -8250.00 | 12.57 Million |
| Financing Cash Flow | 711.65 Thousand | 500.13 Thousand | -2.89 Million | 20.98 Million | 858.95 Thousand | -97.73 Thousand |
| Debt repayment | - | - | -9.3 Million | -897.73 Thousand | -800 Thousand | -97.73 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -51.3 Thousand | - | - | - |
| Common Stock Issuance | - | -51.31 Thousand | 6.45 Million | 7.34 Million | 1.65 Million | 5.68 Million |
| Other Financing Activities | 711.65 Thousand | 551.44 Thousand | -135.00 | 14.54 Million | -13.35 Million | -5.68 Million |
| Accounts receivables | 34.95 Thousand | -17.03 Thousand | 14.88 Thousand | -352.09 Thousand | -415.37 Thousand | 63.27 Thousand |
| Accounts payables | - | 3.38 Million | 2.57 Million | 1 Million | 460.8 Thousand | 540.82 Thousand |
| Inventory | - | - | - | -1 Million | 3.04 Million | - |
| Other working capital | 2.97 Million | 530.42 Thousand | 836.22 Thousand | 1.41 Million | -132.56 Thousand | -4.45 Million |
| Cash at beginning of period | 553.75 Thousand | 152.18 Thousand | 6.84 Million | 593.86 Thousand | 14.21 Million | 15.72 Million |
| Cash at end of period | 506.09 Thousand | 553.75 Thousand | 152.18 Thousand | 6.84 Million | 6.84 Million | 14.21 Million |
| Capital Expenditure | - | - | -6454.00 | -182.97 Thousand | -96.91 Thousand | -63.26 Thousand |
| Effect of forex changes on cash | 42.21 Thousand | 69.94 Thousand | -26.08 Thousand | -6651.00 | -4637.00 | -2014.00 |
| Net cash flow / Change in cash | -47.65 Thousand | 401.57 Thousand | -6.69 Million | 6.25 Million | -7.37 Million | -1.5 Million |
| Free Cash Flow | -801.52 Thousand | -168.51 Thousand | -3.76 Million | -28.37 Million | -8.22 Million | -14.51 Million |
1312
ADVBOX
KREONFIN
MOC
TTEC
BTBIF